Dr. Michael F. Jackson
Assistant Professor
Pharmacology & Therapeutics
Canada
Biography
Dr. Michael F. Jackson is a Professor in the Department of& Pharmacology & Therapeutics at the University of Manitoba, Canada.
Research Interest
Alzheimer’s disease (AD) is a fatal neurodegenerative disorder characterized by progressive dementia and memory loss. AD and related dementias currently affect half a million Canadians. Moreover, ~100 000 new cases are diagnosed each year. However, a recent report, commissioned by the Alzheimer Society of Canada, suggests that within a generation over 1 million Canadians will be afflicted and the economic burden will grow to over $150 billion/year. These projections underscore the importance of identifying novel targets for the development of therapeutics agents effective in the prevention and management of neurodegeneration.
Publications
-
Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus. J Pharmacol Exp Ther. 2016
-
Commemorating John F. MacDonald and the Art of Being a Mentor. Can J Neurol Sci. 2016
-
STEP activation by Gαq coupled GPCRs opposes Src regulation of NMDA receptors containing the GluN2A subunit. Sci Rep. 2016